• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受腕管松解术的日本患者的腱鞘和心脏转甲状腺素蛋白淀粉样变性

Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.

作者信息

Sugiura Kenta, Kozuki Hiroki, Ueba Hiroaki, Kubo Toru, Ochi Yuri, Baba Yuichi, Miyagawa Kazuya, Noguchi Tatsuya, Hirota Takayoshi, Yamasaki Naohito, Wada Noriko, Nakashima Junko, Murakami Ichiro, Ikeuchi Masahiko, Kitaoka Hiroaki

机构信息

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University Nankoku Japan.

Department of Orthopedic Surgery, Kochi Medical School, Kochi University Nankoku Japan.

出版信息

Circ Rep. 2021 May 27;3(6):338-344. doi: 10.1253/circrep.CR-21-0046.

DOI:10.1253/circrep.CR-21-0046
PMID:34136709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8180371/
Abstract

Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) is a life-threatening progressive disease. Recent studies have shown that the detection of transthyretin (TTR) amyloid in tenosynovial tissue may play an important role in the diagnosis of cardiac amyloidosis. The aim of this study was to determine the prevalence of TTR amyloid deposits in surgical tissue of patients undergoing carpal tunnel surgery and to clarify the clinical significance of concomitant cardiac examination with Tc-labeled pyrophosphate (Tc-PYP) scintigraphy in those patients with TTR deposition. We evaluated 79 consecutive patients undergoing carpal tunnel release surgery and biopsy of tenosynovial tissue. The mean (±SD) age of the patients at surgery was 71.6±12.5 years (range 30-95 years); 32 patients (41%) were male. TTR amyloid deposition in tenosynovial tissue was observed in 27 patients (34%). Sixteen of those 27 patients underwent Tc-PYP scintigraphy. Of those 16 patients, 3 (19%) had Grade 2 uptake on Tc-PYP scintigraphy. None of the 3 patients with a diagnosis of ATTRwt-CA had apparent cardiac symptoms and left ventricular wall thickness >13 mm. Concomitant cardiac examination with Tc-PYP scintigraphy in patients who had TTR amyloid deposition in tenosynovial tissue resulted in the identification of 19% of patients with a diagnosis of ATTRwt-CA. This diagnostic approach seems to be useful for the early diagnosis of the disease.

摘要

野生型转甲状腺素蛋白心脏淀粉样变性(ATTRwt-CA)是一种危及生命的进行性疾病。最近的研究表明,在腱鞘组织中检测转甲状腺素蛋白(TTR)淀粉样蛋白可能在心脏淀粉样变性的诊断中发挥重要作用。本研究的目的是确定接受腕管手术患者手术组织中TTR淀粉样蛋白沉积的患病率,并阐明在那些有TTR沉积的患者中,用锝标记焦磷酸盐(Tc-PYP)闪烁扫描进行心脏检查的临床意义。我们评估了79例连续接受腕管松解手术和腱鞘组织活检的患者。手术时患者的平均(±标准差)年龄为71.6±12.5岁(范围30-95岁);32例患者(41%)为男性。在27例患者(34%)的腱鞘组织中观察到TTR淀粉样蛋白沉积。这27例患者中有16例接受了Tc-PYP闪烁扫描。在这16例患者中,3例(19%)在Tc-PYP闪烁扫描中有2级摄取。3例诊断为ATTRwt-CA的患者均无明显心脏症状,左心室壁厚度>13 mm。在腱鞘组织中有TTR淀粉样蛋白沉积的患者中,用Tc-PYP闪烁扫描进行心脏检查,结果发现19%的患者诊断为ATTRwt-CA。这种诊断方法似乎对该疾病的早期诊断有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f2/8180371/88ad8d7799a3/circrep-3-338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f2/8180371/8c9d11ec5923/circrep-3-338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f2/8180371/88ad8d7799a3/circrep-3-338-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f2/8180371/8c9d11ec5923/circrep-3-338-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75f2/8180371/88ad8d7799a3/circrep-3-338-g002.jpg

相似文献

1
Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.接受腕管松解术的日本患者的腱鞘和心脏转甲状腺素蛋白淀粉样变性
Circ Rep. 2021 May 27;3(6):338-344. doi: 10.1253/circrep.CR-21-0046.
2
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.腕管松解术患者的腱鞘炎和心脏淀粉样变性。
J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.
3
Prevalence of Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release With Amyloid Deposition.腕管松解术中伴有淀粉样蛋白沉积患者的心脏淀粉样变性患病率。
Circ J. 2023 Jul 25;87(8):1047-1055. doi: 10.1253/circj.CJ-23-0223. Epub 2023 Jun 13.
4
Combination of Commonly Examined Parameters Is a Useful Predictor of Positive Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.联合常规检查参数是预测老年疑似转甲状腺素蛋白心脏淀粉样变患者 Tc 标记焦磷酸盐闪烁显像阳性的有用指标。
Circ J. 2019 Jul 25;83(8):1698-1708. doi: 10.1253/circj.CJ-19-0255. Epub 2019 Jun 13.
5
Non-invasive detection and differentiation of cardiac amyloidosis using Tc-pyrophosphate scintigraphy and C-Pittsburgh compound B PET imaging.使用 Tc-焦磷酸盐闪烁扫描和 C-Pittsburgh 化合物 B PET 成像进行非侵入性心脏淀粉样变性的检测和鉴别。
Amyloid. 2020 Dec;27(4):266-274. doi: 10.1080/13506129.2020.1798223. Epub 2020 Jul 28.
6
Utility of Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.锝-焦磷酸盐闪烁扫描术在实际临床实践中诊断转甲状腺素蛋白型心脏淀粉样变的效用
Circ Rep. 2019 Jun 14;1(7):277-285. doi: 10.1253/circrep.CR-19-0015.
7
Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and Tc-pyrophosphate scintigraphy.采用高敏心肌肌钙蛋白 T 测定和 Tc-焦磷酸盐闪烁照相术对野生型转甲状腺素蛋白心脏淀粉样变性进行综合诊断。
J Cardiol. 2020 Jan;75(1):12-19. doi: 10.1016/j.jjcc.2019.05.011. Epub 2019 Jul 16.
8
Preclinical diagnosis of wild-type transthyretin amyloid cardiomyopathy in a patient undergoing carpal tunnel release.在一名接受腕管松解术的患者中对野生型转甲状腺素蛋白淀粉样心肌病进行临床前诊断。
J Cardiol Cases. 2021 May 21;24(5):250-253. doi: 10.1016/j.jccase.2021.04.012. eCollection 2021 Nov.
9
Association between spinal stenosis and wild-type ATTR amyloidosis.脊柱狭窄与野生型 ATTR 淀粉样变性的关联。
Amyloid. 2021 Dec;28(4):226-233. doi: 10.1080/13506129.2021.1950681. Epub 2021 Jul 15.
10
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.99mTc-羟甲基二膦酸盐闪烁显像诊断转甲状腺素心脏淀粉样变性准确性的研究。
J Nucl Cardiol. 2019 Apr;26(2):497-504. doi: 10.1007/s12350-017-0922-z. Epub 2017 May 23.

引用本文的文献

1
Carpal tunnel syndrome with both AA amyloidosis and elderly-onset Still disease: A case report.伴有AA型淀粉样变性和老年起病型斯蒂尔病的腕管综合征:一例报告
Medicine (Baltimore). 2025 Sep 5;104(36):e44327. doi: 10.1097/MD.0000000000044327.
2
Amyloidosis Screening by Biopsy During Carpal Tunnel Release: A Systematic Review and Meta-analysis.腕管松解术中通过活检进行淀粉样变性筛查:一项系统评价和荟萃分析。
Plast Reconstr Surg Glob Open. 2025 May 28;13(5):e6816. doi: 10.1097/GOX.0000000000006816. eCollection 2025 May.
3
Prevalence of amyloid deposition and cardiac amyloidosis in shoulder disease compared to carpal tunnel syndrome.

本文引用的文献

1
Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.野生型转甲状腺素蛋白淀粉样变性日本患者中期死亡率的预测
Circ Rep. 2020 Apr 29;2(6):314-321. doi: 10.1253/circrep.CR-20-0031.
2
Validation of the Kumamoto criteria for prediction of technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.验证熊本标准对锝焦磷酸盐闪烁扫描阳性的预测作用作为诊断转甲状腺素蛋白心脏淀粉样变的策略:高知县的一项回顾性队列研究。
J Cardiol. 2021 Feb;77(2):124-130. doi: 10.1016/j.jjcc.2020.06.019. Epub 2020 Oct 22.
3
与腕管综合征相比,肩部疾病中淀粉样蛋白沉积和心脏淀粉样变性的患病率。
JSES Int. 2023 Dec 7;8(2):349-354. doi: 10.1016/j.jseint.2023.11.009. eCollection 2024 Mar.
4
Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review.与转甲状腺素蛋白介导的(ATTR)淀粉样变性相关的肌肉骨骼表现:系统评价。
BMC Musculoskelet Disord. 2023 Sep 22;24(1):751. doi: 10.1186/s12891-023-06853-5.
5
Amyloidosis: What does pathology offer? The evolving field of tissue biopsy.淀粉样变性:病理学能提供什么?组织活检的发展领域。
Front Cardiovasc Med. 2022 Dec 5;9:1081098. doi: 10.3389/fcvm.2022.1081098. eCollection 2022.
6
Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).在腕管综合征手术(CACTuS)患者中鉴定野生型转甲状腺素蛋白心脏淀粉样变性。
ESC Heart Fail. 2023 Feb;10(1):234-244. doi: 10.1002/ehf2.14173. Epub 2022 Oct 3.
JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis.
《日本循环学会2020年心脏淀粉样变性诊断与治疗指南》
Circ J. 2020 Aug 25;84(9):1610-1671. doi: 10.1253/circj.CJ-20-0110. Epub 2020 Aug 21.
4
A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis.关于转甲状腺素蛋白心脏淀粉样变患者塔法米迪司给药的声明。
Circ J. 2019 Dec 25;84(1):15-17. doi: 10.1253/circj.CJ-19-0811. Epub 2019 Nov 16.
5
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.转甲状腺素蛋白心脏淀粉样变:诊断与治疗的最新进展。
ESC Heart Fail. 2019 Dec;6(6):1128-1139. doi: 10.1002/ehf2.12518. Epub 2019 Sep 25.
6
Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.腕管综合征与淀粉样变性、心力衰竭和不良心血管结局的关联。
J Am Coll Cardiol. 2019 Jul 9;74(1):15-23. doi: 10.1016/j.jacc.2019.04.054.
7
Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome.腕管综合征患者中心脏淀粉样变性的患病率。
J Cardiovasc Transl Res. 2019 Dec;12(6):507-513. doi: 10.1007/s12265-019-09895-0. Epub 2019 Jun 18.
8
Combination of Commonly Examined Parameters Is a Useful Predictor of Positive Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.联合常规检查参数是预测老年疑似转甲状腺素蛋白心脏淀粉样变患者 Tc 标记焦磷酸盐闪烁显像阳性的有用指标。
Circ J. 2019 Jul 25;83(8):1698-1708. doi: 10.1253/circj.CJ-19-0255. Epub 2019 Jun 13.
9
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.腕管松解术患者的腱鞘炎和心脏淀粉样变性。
J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.
10
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.